Aims & scope
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Experimental Hematology & Oncology is the companion journal of Journal of Hematology & Oncology.
"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. Experimental Hematology & Oncology also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."
2017 Journal Metrics
32 days to first decision for reviewed manuscripts only
30 days to first decision for all manuscripts
56 days from submission to acceptance
11 days from acceptance to publication
0.742 - Source Normalized Impact per Paper (SNIP)
0.842 - SCImago Journal Rank (SJR)
2.480 - Citescore
111 Altmetric Mentions